ESLA

Estrella Immunopharma, Inc. ESLA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$4.99M total
ARMISTICE CAPITAL, LLC
$4.13M-3.0%
VANGUARD CAPITAL MANAGEMENT LLC
$433.5K+9.0%
GEODE CAPITAL MANAGEMENT, LLC
$147.0K-10.3%
VANGUARD FIDUCIARY TRUST CO
$67.5K0.0%
BlackRock, Inc.
$54.1K+30.4%
STATE STREET CORP
$45.0K0.0%
RENAISSANCE TECHNOLOGIES LLC
$40.7K-37.7%
NORTHERN TRUST CORP
$36.3K+77.6%
US BANCORP \DE\
$20.8K+18.3%
Tower Research Capital LLC (TRC)
$3.4K-31.9%
UBS Group AG
$1.8K-88.6%
TORONTO DOMINION BANK
$1.1K0.0%
WOLVERINE ASSET MANAGEMENT LLC
$4870.0%
BARCLAYS PLC
$131New
Caitong International Asset Management Co., Ltd
$2New
See all 15 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q4 2026
EDGAR

EPS (Diluted)

Q4 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ESLA

Earnings Per Share

13fpro.ai/company/ESLA

Loading ratio trend…

ESLA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Estrella Immunopharma, Inc. (ESLA): stock profile, AI score and financials

Estrella Immunopharma, Inc. (ESLA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ESLA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ESLA by reported 13-F value include ARMISTICE CAPITAL, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. ESLA trades on the Nasdaq exchange and files with the SEC under CIK 1844417. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ESLA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Estrella Immunopharma, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1844417 →